Wed. 15 May 2024, 8:04am ET
Benzinga
Earnings, Earnings Beats, News
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 6.25 percent increase over losses of $(0.32) per share from the same period last year.